Cipher Pharmaceuticals (CPHRF) Stock Statistics & Valuation Metrics

Cipher Pharmaceuticals has a market cap or net worth of $203.99M. The enterprise value is $425.81M.

Cipher Pharmaceuticals has 25.61M shares outstanding. The number of shares has decreased by -2.65% in one year.

Cipher Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Cipher Pharmaceuticals is ―. Cipher Pharmaceuticals’s PEG ratio is ―.

In the last 12 months, Cipher Pharmaceuticals had revenue of $26.46M and earned $15.86M in profits. Earnings per share was $0.66.

In the last 12 months, operating cash flow was $13.08M and capital expenditures -$58.00K, giving a free cash flow of $13.02M billion.

Cipher Pharmaceuticals pays an annual dividend of , resulting in a dividend yield of

Cipher Pharmaceuticals upcoming earnings date is May 8, 2025, Before Open.

Cipher Pharmaceuticals as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Cipher Pharmaceuticals has paid -$6.37M in taxes.

Cipher Pharmaceuticals EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Cipher Pharmaceuticals has $9.52M in cash and marketable securities with $40.75M in debt, giving a net cash position of $31.23M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Cipher Pharmaceuticals is $10.64, which is 11.43% higher than the current price. The consensus rating is Moderate Buy